Epic™ Aortic and Mitral

Exceptional Durability
ACROSS PATIENT
POPULATIONS

DURABILITY THAT WITHSTANDS THE LONG-TERM
TEST OF TIME

The Epic™ stented tissue valves with Linx™ anticalcification (AC) technology has impressive 10-year durability data. And it stands on the legacy of the 20 years of published durability data and 25 years of clinical experience from the Biocor™ valve.*

 

 

AT 10 YEARS

Freedom from SVD,
all patient ages (Epic™ Mitral)1
Freedom from SVD,
all patient ages (Epic™ Aortic)2

*Based on available 10+ and 20+ year retrospective studies.
**From stand-alone aortic or mitral valve replacements.

 

Epic™ Mitral Valve Carries on the Long-Term Success of Biocor

When evaluating longer term data from the Epic valve’s predecessor, the Biocor valve,2 its durability—at all patient ages—is impressive compared to the competing PERIMOUNT valve3 and the Hancock II valve.4,*
 

ACTUARIAL Freedom from Reoperation due to Structural Valve Deterioration AT 15 YEARS4,5
 

*NOTE: Data not from head to head studies. Data differences depicted between these trials may not be directly comparable, statistically significant, or clinically meaningful due to differences in trial protocols, endpoints, and/or patient populations. Data provided for informational purposes only.
** Interpolated from Borger data, Figure 5.

EPIC™ SUPRA DELIVERS EXCEPTIONAL DURABILITY AND PERFORMANCE

  • Optimal leaflet design minimizes regurgitation
  • Pericardial shield reduces abrasion by creating tissue-to-tissue interface
  • 20-year Biocor durability data + Epic 10-year durability data shows outstanding Aortic freedom from failure2,6
EPIC™ AORTIC
Freedom from SVD,
at 10 YEARS2
BIOCOR™ AORTIC
Freedom from SVD,
at 20 YEARS6

Strong in vivo hemodynamics

 

*NOTE: For references 7-10, data not from head to head studies. Data differences depicted between these trials may not be directly comparable, statistically significant, or clinically meaningful due to differences in trial protocols, endpoints, and/or patient populations. Data provided for informational purposes only.
**Pressure Gradients approximated through Epic Aortic SSED data matched with stent size equivalencies for the Epic Supra. Per Abbott Internal engineering specifications, a 19 mm Epic Supra has the same stent size as a 21 mm Epic Aortic and this relationship continues across all Epic Supra valve sizes.

MAT-2006197 v1.0

References
  1. Lehmann S, Jawad K, Meyer A, et al. Long-term follow-up after porcine xenograft mitral valve replacement. Presented at: 2017 American Association For Thoracic Surgery Mitral Conclave. April 27-28, 2017; New York, NY, USA.
  2. Lehmann, S, Merk DR, Etz CD, et al. Porcine xenograft for aortic, mitral and double valve replacement: long-term results of 2544 consecutive patients. Eur J Cardiothorac Surg. 2016;49:1150–1156.
  3. Bourguignon T, Bouquiaux-Stablo AL, Loardi C, et al. Very late outcomes for mitral valve replacement with the Carpentier-Edwards pericardial bioprosthesis: 25-year follow-up of 450 implantations. J Thorac Cardiovasc Surg. 2014;148:2004-2011.
  4. Borger MA, Ivanov J, Armstrong S, et al. Twenty-year results of the Hancock II bioprosthesis. J Heart Valve Dis. 2006;15:49-56
  5. Mykén PS,  Bech-Hansen O. A 20-year experience of 1712 patients with the Biocor porcine bioprosthesis. J Thorac Cardiovasc Surg. 2009;137:76-81
  6. Eichinger WB,  Hettich IM, Ruzicka DJ, et al. Twenty-year experience with the St. Jude Medical Biocor bioprosthesis in the aortic position. The Annals of Thoracic Surgery 2008;86(4):1204-1210.
  7. Epic™ Supra SSED.
  8. Mosaic Instructions for Use.
  9. Resilia Instructions for Use.
  10. Magna Ease Instructions for Use.
     

This site uses cookies to improve your experience.

To find out more please read our Privacy and Cookies policy.

Ok

Sign up

Receive updates from Abbott Structural Heart

YOU ARE ABOUT TO ENTER AN ABBOTT COUNTRY OR REGION SPECIFIC WEBSITE.

Please be aware that the website you have requested is intended for the residents of a particular country or countries, as noted on that site. As a result, the site may contain information on pharmaceuticals, medical devices and other products or uses of the product that are not approved in other countries or regions.